Glaxosmithkline Pharmaceuticals Q4 Results
- BSE: 500660
- NSE: GLAXO
- ISIN: INE159A01016
- Sector: Biotechnology & Drugs
BSE
2,345.9
-69.30 (-2.87%)
-69.30 (-2.87%)Volume4.41 K
Updated: Mon 25 Nov, 2024 | 15:40:02
NSE
2,341.65-70.15 (-2.91%)
-70.15 (-2.91%)Volume1.12 L
Updated: Mon 25 Nov, 2024 | 15:43:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Glaxosmithkline Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 22 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 929.80 | 802.30 | -% | 787.45 | -% |
| Selling/ General/ Admin Expenses Total | 172.83 | 152.99 | -% | 148.84 | -% |
| Depreciation/ Amortization | 18.10 | 16.41 | -% | 17.18 | -% |
| Other Operating Expenses Total | 132.58 | 132.53 | -% | 124.08 | -% |
| Total Operating Expense | 690.64 | 601.38 | -% | 624.49 | -% |
| Operating Income | 239.16 | 200.92 | -% | 162.96 | -% |
| Net Income Before Taxes | 270.62 | 224.25 | -% | 189.97 | -% |
| Net Income | 194.48 | 164.56 | -% | 133.43 | -% |
| Diluted Normalized EPS | 11.38 | 10.20 | -% | 7.45 | -% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST